Review



primary antibodies against srf  (ABclonal Biotechnology)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    ABclonal Biotechnology primary antibodies against srf
    Primary Antibodies Against Srf, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against srf/product/ABclonal Biotechnology
    Average 90 stars, based on 1 article reviews
    primary antibodies against srf - by Bioz Stars, 2026-03
    90/100 stars

    Images



    Similar Products

    primary antibodies against srf  (ABclonal Biotechnology)
    90
    ABclonal Biotechnology primary antibodies against srf
    Primary Antibodies Against Srf, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against srf/product/ABclonal Biotechnology
    Average 90 stars, based on 1 article reviews
    primary antibodies against srf - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    primary antibodies against srf  (Santa Cruz Biotechnology)
    95
    Santa Cruz Biotechnology primary antibodies against srf
    Serum response factor promotes OSCC cell epithelial-to-mesenchymal transition. Serum-starved OSCC cells (SAS and HSC3) were transfected with <t>pCGN-SRF</t> or Ctrl vectors. At 72 h post-transfection, the protein levels <t>of</t> <t>E-cadherin</t> and N-cadherin were detected via western blotting. GAPDH served as a protein loading control ( A ). Original western blots are shown in . The relative band intensity was determined through densitometric analysis ( B ). Data are presented as the mean ± SD of three independent experiments. ** p < 0.01 vs. control vector. ( C ) Immunofluorescence staining of E-cadherin in SAS and HSC3 cells transfected with pCGN-SRF or Ctrl vectors. ( D ) Immunofluorescence staining of N-cadherin in SAS and HSC3 cells transfected with pCGN-SRF or control (Ctrl) vector. Scale bar: 50μm. Data are representative of three independent experiments. Ctrl, control; E-cad, E-cadherin; N-cad, N-cadherin; OSCC, oral squamous cell carcinoma.
    Primary Antibodies Against Srf, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against srf/product/Santa Cruz Biotechnology
    Average 95 stars, based on 1 article reviews
    primary antibodies against srf - by Bioz Stars, 2026-03
    95/100 stars
    		  Buy from Supplier
    primary antibody against srf  (ZSGB Biotech)
    90
    ZSGB Biotech primary antibody against srf
    Serum response factor promotes OSCC cell epithelial-to-mesenchymal transition. Serum-starved OSCC cells (SAS and HSC3) were transfected with <t>pCGN-SRF</t> or Ctrl vectors. At 72 h post-transfection, the protein levels <t>of</t> <t>E-cadherin</t> and N-cadherin were detected via western blotting. GAPDH served as a protein loading control ( A ). Original western blots are shown in . The relative band intensity was determined through densitometric analysis ( B ). Data are presented as the mean ± SD of three independent experiments. ** p < 0.01 vs. control vector. ( C ) Immunofluorescence staining of E-cadherin in SAS and HSC3 cells transfected with pCGN-SRF or Ctrl vectors. ( D ) Immunofluorescence staining of N-cadherin in SAS and HSC3 cells transfected with pCGN-SRF or control (Ctrl) vector. Scale bar: 50μm. Data are representative of three independent experiments. Ctrl, control; E-cad, E-cadherin; N-cad, N-cadherin; OSCC, oral squamous cell carcinoma.
    Primary Antibody Against Srf, supplied by ZSGB Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibody against srf/product/ZSGB Biotech
    Average 90 stars, based on 1 article reviews
    primary antibody against srf - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    primary antibodies against srf sc-335  (Santa Cruz Biotechnology)
    90
    Santa Cruz Biotechnology primary antibodies against srf sc-335
    Serum response factor promotes OSCC cell epithelial-to-mesenchymal transition. Serum-starved OSCC cells (SAS and HSC3) were transfected with <t>pCGN-SRF</t> or Ctrl vectors. At 72 h post-transfection, the protein levels <t>of</t> <t>E-cadherin</t> and N-cadherin were detected via western blotting. GAPDH served as a protein loading control ( A ). Original western blots are shown in . The relative band intensity was determined through densitometric analysis ( B ). Data are presented as the mean ± SD of three independent experiments. ** p < 0.01 vs. control vector. ( C ) Immunofluorescence staining of E-cadherin in SAS and HSC3 cells transfected with pCGN-SRF or Ctrl vectors. ( D ) Immunofluorescence staining of N-cadherin in SAS and HSC3 cells transfected with pCGN-SRF or control (Ctrl) vector. Scale bar: 50μm. Data are representative of three independent experiments. Ctrl, control; E-cad, E-cadherin; N-cad, N-cadherin; OSCC, oral squamous cell carcinoma.
    Primary Antibodies Against Srf Sc 335, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against srf sc-335/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    primary antibodies against srf sc-335 - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    primary antibodies against serum response factor (srf), erk1/2, p38, jnk/sapk, p-jnk/sapk, c-jun  (Cell Signaling Technology Inc)
    90
    Cell Signaling Technology Inc primary antibodies against serum response factor (srf), erk1/2, p38, jnk/sapk, p-jnk/sapk, c-jun
    Serum response factor promotes OSCC cell epithelial-to-mesenchymal transition. Serum-starved OSCC cells (SAS and HSC3) were transfected with <t>pCGN-SRF</t> or Ctrl vectors. At 72 h post-transfection, the protein levels <t>of</t> <t>E-cadherin</t> and N-cadherin were detected via western blotting. GAPDH served as a protein loading control ( A ). Original western blots are shown in . The relative band intensity was determined through densitometric analysis ( B ). Data are presented as the mean ± SD of three independent experiments. ** p < 0.01 vs. control vector. ( C ) Immunofluorescence staining of E-cadherin in SAS and HSC3 cells transfected with pCGN-SRF or Ctrl vectors. ( D ) Immunofluorescence staining of N-cadherin in SAS and HSC3 cells transfected with pCGN-SRF or control (Ctrl) vector. Scale bar: 50μm. Data are representative of three independent experiments. Ctrl, control; E-cad, E-cadherin; N-cad, N-cadherin; OSCC, oral squamous cell carcinoma.
    Primary Antibodies Against Serum Response Factor (Srf), Erk1/2, P38, Jnk/Sapk, P Jnk/Sapk, C Jun, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against serum response factor (srf), erk1/2, p38, jnk/sapk, p-jnk/sapk, c-jun/product/Cell Signaling Technology Inc
    Average 90 stars, based on 1 article reviews
    primary antibodies against serum response factor (srf), erk1/2, p38, jnk/sapk, p-jnk/sapk, c-jun - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    primary antibodies against srf (sc-335)  (Santa Cruz Biotechnology)
    90
    Santa Cruz Biotechnology primary antibodies against srf (sc-335)
    Serum response factor promotes OSCC cell epithelial-to-mesenchymal transition. Serum-starved OSCC cells (SAS and HSC3) were transfected with <t>pCGN-SRF</t> or Ctrl vectors. At 72 h post-transfection, the protein levels <t>of</t> <t>E-cadherin</t> and N-cadherin were detected via western blotting. GAPDH served as a protein loading control ( A ). Original western blots are shown in . The relative band intensity was determined through densitometric analysis ( B ). Data are presented as the mean ± SD of three independent experiments. ** p < 0.01 vs. control vector. ( C ) Immunofluorescence staining of E-cadherin in SAS and HSC3 cells transfected with pCGN-SRF or Ctrl vectors. ( D ) Immunofluorescence staining of N-cadherin in SAS and HSC3 cells transfected with pCGN-SRF or control (Ctrl) vector. Scale bar: 50μm. Data are representative of three independent experiments. Ctrl, control; E-cad, E-cadherin; N-cad, N-cadherin; OSCC, oral squamous cell carcinoma.
    Primary Antibodies Against Srf (Sc 335), supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibodies against srf (sc-335)/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    primary antibodies against srf (sc-335) - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    primary antibody against human transcription factor srf  (Santa Cruz Biotechnology)
    90
    Santa Cruz Biotechnology primary antibody against human transcription factor srf
    Serum response factor promotes OSCC cell epithelial-to-mesenchymal transition. Serum-starved OSCC cells (SAS and HSC3) were transfected with <t>pCGN-SRF</t> or Ctrl vectors. At 72 h post-transfection, the protein levels <t>of</t> <t>E-cadherin</t> and N-cadherin were detected via western blotting. GAPDH served as a protein loading control ( A ). Original western blots are shown in . The relative band intensity was determined through densitometric analysis ( B ). Data are presented as the mean ± SD of three independent experiments. ** p < 0.01 vs. control vector. ( C ) Immunofluorescence staining of E-cadherin in SAS and HSC3 cells transfected with pCGN-SRF or Ctrl vectors. ( D ) Immunofluorescence staining of N-cadherin in SAS and HSC3 cells transfected with pCGN-SRF or control (Ctrl) vector. Scale bar: 50μm. Data are representative of three independent experiments. Ctrl, control; E-cad, E-cadherin; N-cad, N-cadherin; OSCC, oral squamous cell carcinoma.
    Primary Antibody Against Human Transcription Factor Srf, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibody against human transcription factor srf/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    primary antibody against human transcription factor srf - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    primary antibody against srf  (Santa Cruz Biotechnology)
    90
    Santa Cruz Biotechnology primary antibody against srf
    Serum response factor promotes OSCC cell epithelial-to-mesenchymal transition. Serum-starved OSCC cells (SAS and HSC3) were transfected with <t>pCGN-SRF</t> or Ctrl vectors. At 72 h post-transfection, the protein levels <t>of</t> <t>E-cadherin</t> and N-cadherin were detected via western blotting. GAPDH served as a protein loading control ( A ). Original western blots are shown in . The relative band intensity was determined through densitometric analysis ( B ). Data are presented as the mean ± SD of three independent experiments. ** p < 0.01 vs. control vector. ( C ) Immunofluorescence staining of E-cadherin in SAS and HSC3 cells transfected with pCGN-SRF or Ctrl vectors. ( D ) Immunofluorescence staining of N-cadherin in SAS and HSC3 cells transfected with pCGN-SRF or control (Ctrl) vector. Scale bar: 50μm. Data are representative of three independent experiments. Ctrl, control; E-cad, E-cadherin; N-cad, N-cadherin; OSCC, oral squamous cell carcinoma.
    Primary Antibody Against Srf, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/primary antibody against srf/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    primary antibody against srf - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Serum response factor promotes OSCC cell epithelial-to-mesenchymal transition. Serum-starved OSCC cells (SAS and HSC3) were transfected with pCGN-SRF or Ctrl vectors. At 72 h post-transfection, the protein levels of E-cadherin and N-cadherin were detected via western blotting. GAPDH served as a protein loading control ( A ). Original western blots are shown in . The relative band intensity was determined through densitometric analysis ( B ). Data are presented as the mean ± SD of three independent experiments. ** p < 0.01 vs. control vector. ( C ) Immunofluorescence staining of E-cadherin in SAS and HSC3 cells transfected with pCGN-SRF or Ctrl vectors. ( D ) Immunofluorescence staining of N-cadherin in SAS and HSC3 cells transfected with pCGN-SRF or control (Ctrl) vector. Scale bar: 50μm. Data are representative of three independent experiments. Ctrl, control; E-cad, E-cadherin; N-cad, N-cadherin; OSCC, oral squamous cell carcinoma.

    Journal: Cancers

    Article Title: Serum Response Factor-Regulated IDO1/Kyn-Ahr Pathway Promotes Tumorigenesis of Oral Squamous Cell Carcinoma

    doi: 10.3390/cancers15041319

    Figure Lengend Snippet: Serum response factor promotes OSCC cell epithelial-to-mesenchymal transition. Serum-starved OSCC cells (SAS and HSC3) were transfected with pCGN-SRF or Ctrl vectors. At 72 h post-transfection, the protein levels of E-cadherin and N-cadherin were detected via western blotting. GAPDH served as a protein loading control ( A ). Original western blots are shown in . The relative band intensity was determined through densitometric analysis ( B ). Data are presented as the mean ± SD of three independent experiments. ** p < 0.01 vs. control vector. ( C ) Immunofluorescence staining of E-cadherin in SAS and HSC3 cells transfected with pCGN-SRF or Ctrl vectors. ( D ) Immunofluorescence staining of N-cadherin in SAS and HSC3 cells transfected with pCGN-SRF or control (Ctrl) vector. Scale bar: 50μm. Data are representative of three independent experiments. Ctrl, control; E-cad, E-cadherin; N-cad, N-cadherin; OSCC, oral squamous cell carcinoma.

    Article Snippet: Primary antibodies against SRF (sc-335, Santa Cruz Biotechnology, Dallas, TX, USA), E-cadherin (ab76055; Abcam, Cambridge, UK), and N-cadherin (13769-1-AP, Proteintech, Wuhan, Hubei, China) were applied.

    Techniques: Transfection, Western Blot, Control, Plasmid Preparation, Immunofluorescence, Staining

    SRF overexpression promotes OSCC tumorigenesis in vivo. Xenografted nude mice ( n = 6/group) were injected with HSC3 cells stably overexpressing SRF. The mice were euthanized, and tumors were excised from nude mice 40 days after HSC-3 cell injection ( A ). Tumor volumes were measured using calipers ( B ), and tumors were weighed at the end of the experiment ( C ). Statistical data were derived from three independent measurements and are shown as means ± SDs. Infiltration of HSC-3-SRF tumor cells ( D ). Representative immunohistochemical images of E-cadherin and N-cadherin expression in samples from HSC-3-NC and HSC-3-SRF cells ( E ). The scale bar is shown in lower-right corner. Mean optical density of E-cadherin and N-cadherin in tumor samples from HSC-3-NC and HSC-3-SRF cells ( F ). * p < 0.05, ** p < 0.01, *** p < 0.001, tumor samples from HSC-3-NC cells compared with HSC-3-SRF cells. NC, negative control; OSCC, oral squamous cell carcinoma; SRF, serum response factor.

    Journal: Cancers

    Article Title: Serum Response Factor-Regulated IDO1/Kyn-Ahr Pathway Promotes Tumorigenesis of Oral Squamous Cell Carcinoma

    doi: 10.3390/cancers15041319

    Figure Lengend Snippet: SRF overexpression promotes OSCC tumorigenesis in vivo. Xenografted nude mice ( n = 6/group) were injected with HSC3 cells stably overexpressing SRF. The mice were euthanized, and tumors were excised from nude mice 40 days after HSC-3 cell injection ( A ). Tumor volumes were measured using calipers ( B ), and tumors were weighed at the end of the experiment ( C ). Statistical data were derived from three independent measurements and are shown as means ± SDs. Infiltration of HSC-3-SRF tumor cells ( D ). Representative immunohistochemical images of E-cadherin and N-cadherin expression in samples from HSC-3-NC and HSC-3-SRF cells ( E ). The scale bar is shown in lower-right corner. Mean optical density of E-cadherin and N-cadherin in tumor samples from HSC-3-NC and HSC-3-SRF cells ( F ). * p < 0.05, ** p < 0.01, *** p < 0.001, tumor samples from HSC-3-NC cells compared with HSC-3-SRF cells. NC, negative control; OSCC, oral squamous cell carcinoma; SRF, serum response factor.

    Article Snippet: Primary antibodies against SRF (sc-335, Santa Cruz Biotechnology, Dallas, TX, USA), E-cadherin (ab76055; Abcam, Cambridge, UK), and N-cadherin (13769-1-AP, Proteintech, Wuhan, Hubei, China) were applied.

    Techniques: Over Expression, In Vivo, Injection, Stable Transfection, Derivative Assay, Immunohistochemical staining, Expressing, Negative Control

    SRF facilitates the migration and invasion of OSCC by upregulating IDO1 transcription. ( A ) Migration and invasion assays on SAS and HSC-3 cells incubated with the IDO1 inhibitor PC. Immunofluorescence staining of AhR ( B ), E-cadherin ( C ), and N-cadherin ( D ) in SAS and HSC-3 cells after adding PC. The scale bar is shown in lower-right corner. ( E ) Western blotting results of AhR, E-cadherin, and N-cadherin in SAS and HSC-3 cells after adding PC. Original western blots are shown in . AhR, aryl hydrocarbon receptor; E-cad, E-cadherin; IDO1, indoleamine 2,3-dioxygenase 1; N-cad, N-cadherin; OSCC, oral squamous cell carcinoma; PC, palmatine chloride; SRF, serum response factor.

    Journal: Cancers

    Article Title: Serum Response Factor-Regulated IDO1/Kyn-Ahr Pathway Promotes Tumorigenesis of Oral Squamous Cell Carcinoma

    doi: 10.3390/cancers15041319

    Figure Lengend Snippet: SRF facilitates the migration and invasion of OSCC by upregulating IDO1 transcription. ( A ) Migration and invasion assays on SAS and HSC-3 cells incubated with the IDO1 inhibitor PC. Immunofluorescence staining of AhR ( B ), E-cadherin ( C ), and N-cadherin ( D ) in SAS and HSC-3 cells after adding PC. The scale bar is shown in lower-right corner. ( E ) Western blotting results of AhR, E-cadherin, and N-cadherin in SAS and HSC-3 cells after adding PC. Original western blots are shown in . AhR, aryl hydrocarbon receptor; E-cad, E-cadherin; IDO1, indoleamine 2,3-dioxygenase 1; N-cad, N-cadherin; OSCC, oral squamous cell carcinoma; PC, palmatine chloride; SRF, serum response factor.

    Article Snippet: Primary antibodies against SRF (sc-335, Santa Cruz Biotechnology, Dallas, TX, USA), E-cadherin (ab76055; Abcam, Cambridge, UK), and N-cadherin (13769-1-AP, Proteintech, Wuhan, Hubei, China) were applied.

    Techniques: Migration, Incubation, Immunofluorescence, Staining, Western Blot

    AhR is involved in the function of SRF in carcinogenesis. ( A ) Migration and invasion assays on SAS and HSC-3 cells after adding the AhR inhibitor PDM2. Immunofluorescence staining of AhR ( B ), E-cadherin ( C ), and N-cadherin ( D ) in SAS and HSC-3 cells after adding PDM2. The scale bar is shown in lower-right corner. ( E ) Western blotting results of AhR, E-cadherin, and N-cadherin in SAS and HSC-3 cells after adding PDM2. Original western blots are shown in . AhR, aryl hydrocarbon receptor; E-cad, E-cadherin; N-cad, N-cadherin; OSCC, oral squamous cell carcinoma; PDM2, AhR inhibitor; SRF, serum response factor.

    Journal: Cancers

    Article Title: Serum Response Factor-Regulated IDO1/Kyn-Ahr Pathway Promotes Tumorigenesis of Oral Squamous Cell Carcinoma

    doi: 10.3390/cancers15041319

    Figure Lengend Snippet: AhR is involved in the function of SRF in carcinogenesis. ( A ) Migration and invasion assays on SAS and HSC-3 cells after adding the AhR inhibitor PDM2. Immunofluorescence staining of AhR ( B ), E-cadherin ( C ), and N-cadherin ( D ) in SAS and HSC-3 cells after adding PDM2. The scale bar is shown in lower-right corner. ( E ) Western blotting results of AhR, E-cadherin, and N-cadherin in SAS and HSC-3 cells after adding PDM2. Original western blots are shown in . AhR, aryl hydrocarbon receptor; E-cad, E-cadherin; N-cad, N-cadherin; OSCC, oral squamous cell carcinoma; PDM2, AhR inhibitor; SRF, serum response factor.

    Article Snippet: Primary antibodies against SRF (sc-335, Santa Cruz Biotechnology, Dallas, TX, USA), E-cadherin (ab76055; Abcam, Cambridge, UK), and N-cadherin (13769-1-AP, Proteintech, Wuhan, Hubei, China) were applied.

    Techniques: Migration, Immunofluorescence, Staining, Western Blot